Alteplase

Hospital Pharmacy

Volumn 37, Issue 2, 2002, Pages 148-154

  Cada, Dennis J ^a   Levien, Terri ^a   Baker, Danial E ^a  

^a WASHINGTON STATE UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ALTEPLASE; BOSENTAN; CATHFLO ACTIVASE; DROTRECOGIN; ERTAPENEM; RECOMBINANT INTERLEUKIN 1 RECEPTOR BLOCKING AGENT; VALDECOXIB;

CENTRAL VENOUS CATHETER; CLINICAL PHARMACY; CLINICAL TRIAL; DEEP VEIN THROMBOSIS; DRUG FORMULARY; DRUG INFORMATION; DRUG UTILIZATION; GASTROINTESTINAL HEMORRHAGE; HOSPITAL PHARMACY; HUMAN; MEDICAL LITERATURE; NURSING; PHARMACY; PHASE 3 CLINICAL TRIAL; PUBLICATION; REVIEW; SEPSIS; THROMBOSIS;

EID: 0036123184     PISSN: 00185787     EISSN: None     Source Type: Journal    
DOI: 10.1177/001857870203700210     Document Type: Review

References (17)

1. Stability and sterility of recombinant tissue plasminogen activator at -30°C
2. Activity and dosage of alteplase dilution for clearing occlusions of venous-access devices
3. Alteplase as an alternative to urokinase
4. Recombinant tissue plasminogen activator for central venous access device occlusion
5. Recombinant tissue plasminogen activator (alteplase) for restoration of flow in occluded central venous access devices: A double-blind placebo-controlled trial - The Cardiovascular Thrombolytic to Open Occluded Lines (COOL) efficacy trial
6. Urokinase versus reconibinant tissue plasminogen activator in thrombosed central venous catheters: A double-blinded, randomized trial
7. The use of alteplase to restore patency of central venous lines in pediatric patients: A cohort study
8. The use of aliquoted and frozen tPA in central venous line occlusions
9. The use of recombinant tissue plasminogen activator (rTPA) in infants and children
10. Safety and efficacy of alteplase (TPA) for the clearance of occluded central venous access devices (CVAD's) in 121 cancer patients
11. Continuous infusion versus bolus instillation of tissue plasminogen activator (TPA) in restoring the patency of occluded central venous access devices (CVADs)
12. Efficacy of tissue plasminogen activator administration on patency of hemodialysis access catheters
13. Treatment of hemodialysis catheter-associated fibrin sheaths by rt-PA infusion: Critical analysis of 124 procedures
14. Thrombolysis of blocked hemodialysis catheter using recombinant tissue-type plasminogen activator
15. Use of tissue plasminogen activator for reopening of clotted dialysis catheters
16. Investigational use of tissue plasminogen activator (t-PA) for occluded central venous catheters